The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte KEVIN P. BAKER, DAVID BOTSTEIN,
LUC DESNOYERS, DAN L. EATON, NAPOLEONE FERRARA,
SHERMAN FONG, WEI-QIANG GAO, AUDREY GODDARD, PAUL J.
GODOWSKI, J. CHRISTOPHER GRIMALDI, AUSTIN L. GURNEY,
KENNETH J. HILLAN, JAMES PAN, NICHOLAS F. PAONI,
MARGARET ANN ROY,VICTORIA SMITH, TIMOTHY A. STEWART,
DANIEL TUMAS, COLIN K. WATANABE, P. MICKEY WILLIAMS,
and WILLIAM I. WOOD
__________
Appeal 2007-1068
Application 10/015,394
Technology Center 1600
__________
DECIDED: May 14, 2007
__________
Before TONI R. SCHEINER, ERIC GRIMES, and NANCY J. LINCK,
Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This appeal under 35 U.S.C. § 134 involves claims to antibodies
directed to a polypeptide designated PRO1760, which the Examiner has
rejected for lack of patentable utility, and lack of enablement. We have
jurisdiction under 35 U.S.C. § 6(b). We affirm.
Page: 1 2 3 4 5 6 7 8 Next
Last modified: September 9, 2013